SMS Pharmaceuticals Limited has addressed concerns regarding the volume/price movement raised by the exchange on September 12, 2025. The company has affirmed its adherence to Regulation 30 of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015.
In its communication, SMS Pharmaceuticals emphasized its commitment to promptly disclosing all material events and information that are price-sensitive and relevant to the company's operations and performance.
The company clarified that it currently has no undisclosed information, announcements, or events that could influence the volume/price behavior of its stock. It attributed the stock's price movement to prevailing market conditions, emphasizing that it is entirely market-driven.
This clarification is in response to the exchange's inquiry regarding the volume/price movement, referenced under Ref. No.: L/SURV/ONL/PV/AA/2025-2026 / 439 dated 12.09.2025.
Thirumalesh Tumma, the Company Secretary of SMS Pharmaceuticals Limited, has signed the clarification.
Discover the latest Business News, Sensex, and Nifty updates. Obtain Personal Finance insights, tax queries, and expert opinions on Moneycontrol or download the Moneycontrol App to stay updated!
Find the best of Al News in one place, specially curated for you every weekend.
Stay on top of the latest tech trends and biggest startup news.
